MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Trims Stock Holdings in Nutrien Ltd. $NTR

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH has significantly reduced its stake in Nutrien Ltd. by 96.5%, now holding only 2,598 shares after selling 72,474 shares in the second quarter.
• Nutrien reported quarterly earnings exceeding analysts' expectations, with an EPS of $2.65, surpassing consensus estimates of $2.41, and a revenue of $10.30 billion.
• The company recently declared a quarterly dividend of $0.545 per share, representing an annualized yield of 3.7%, with a payout ratio of 78.14%.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 96.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,598 shares of the company's stock after selling 72,474 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Nutrien were worth $151,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC raised its holdings in Nutrien by 184.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 12,243 shares of the company's stock valued at $608,000 after buying an additional 7,934 shares during the period. Intech Investment Management LLC raised its holdings in Nutrien by 284.0% in the 1st quarter. Intech Investment Management LLC now owns 69,128 shares of the company's stock valued at $3,430,000 after buying an additional 51,126 shares during the period. Covea Finance raised its holdings in Nutrien by 16.5% in the 2nd quarter. Covea Finance now owns 73,500 shares of the company's stock valued at $4,265,000 after buying an additional 10,400 shares during the period. Farther Finance Advisors LLC raised its holdings in Nutrien by 27.6% in the 1st quarter. Farther Finance Advisors LLC now owns 4,627 shares of the company's stock valued at $229,000 after buying an additional 1,002 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Nutrien by 1.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 736,996 shares of the company's stock valued at $36,607,000 after buying an additional 7,194 shares during the period. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Stock Performance

Shares of Nutrien stock opened at $58.17 on Friday. Nutrien Ltd. has a one year low of $43.69 and a one year high of $65.08. The company has a market cap of $28.22 billion, a PE ratio of 20.85, a P/E/G ratio of 0.97 and a beta of 0.77. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.85 and a current ratio of 1.33. The business has a 50-day simple moving average of $57.81 and a 200-day simple moving average of $56.65.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $2.65 EPS for the quarter, topping analysts' consensus estimates of $2.41 by $0.24. Nutrien had a return on equity of 6.51% and a net margin of 5.25%.The business had revenue of $10.30 billion during the quarter, compared to the consensus estimate of $10.40 billion. During the same period in the previous year, the company posted $2.34 earnings per share. The business's revenue for the quarter was up 2.8% on a year-over-year basis. On average, equities research analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Monday, September 29th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, September 29th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.7%. Nutrien's payout ratio is currently 78.14%.

Wall Street Analysts Forecast Growth

NTR has been the topic of a number of recent research reports. Oppenheimer boosted their price target on shares of Nutrien from $63.00 to $65.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 15th. Raymond James Financial lowered shares of Nutrien from an "outperform" rating to a "market perform" rating and set a $68.00 price target on the stock. in a research note on Tuesday, June 17th. Wells Fargo & Company boosted their price target on shares of Nutrien from $59.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 17th. Jefferies Financial Group cut their price target on shares of Nutrien from $61.00 to $60.00 and set a "hold" rating on the stock in a research note on Tuesday, September 9th. Finally, Morgan Stanley boosted their price target on shares of Nutrien from $60.00 to $65.00 and gave the stock an "equal weight" rating in a research note on Thursday, June 26th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $62.39.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.